Superior vena cava syndrome after implantation of a transvenous cardioverter defibrillator

Eur Heart J. 1995 May;16(5):716-8. doi: 10.1093/oxfordjournals.eurheartj.a060981.

Abstract

Superior vena cava syndrome is a rare, but nevertheless well known complication of permanent pacemaker implantation. Nowadays cardioverter defibrillators are also routinely implanted transvenously. A superior vena cava syndrome occurred in a 48-year-old female 2 years after implantation of cardioverter defibrillator. The clinical problem, in the presence of a predisposing thrombophilic condition (circulating lupus anticoagulant), resolved only partially after treatment with thrombolytics and oral anticoagulation. This syndrome should be recognized as a possible important complication of defibrillator therapy and requires lifelong anticoagulation.

Publication types

  • Case Reports

MeSH terms

  • Defibrillators, Implantable / adverse effects*
  • Female
  • Humans
  • Middle Aged
  • Superior Vena Cava Syndrome / diagnosis
  • Superior Vena Cava Syndrome / etiology*
  • Superior Vena Cava Syndrome / therapy
  • Ventricular Fibrillation / complications
  • Ventricular Fibrillation / therapy*